Up next

Autoplay

Acute Myeloid Leukemia: Examining the Pharmacologic Profiles and Integration of Treatment Advances

0 Views • 07/04/23
Share
Embed
administrator
administrator
Subscribers
0

Earn CME for related activities: https://www.naccme.com/oln

Featuring a presentation by Dr. Christopher A. Fausel, this on-demand webcast examines novel chemotherapeutic formulations and targeted agents in the treatment of AML in terms of clinical outcomes, pharmacologic profiles, reduced toxicity, and pharmacoeconomic data.

© 2018 NACCME, an HMP Company

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay